Evaluation of three immobilization combinations in the capybara (Hydrochoerus hydrochaeris)
Publication Type: |
Journal Article |
Year of Publication: |
2010 |
Authors: |
Jay D. King, Elizabeth Congdon, Carolina Tosta |
Publication/Journal: |
Zoo Biology |
Publisher: |
A Wiley Company, Inc., Wiley Subscription Services |
Keywords: |
atipamezole hcl, butorphanol tartrate, medetomidine hcl, tiletamine hcl, zolazepam hcl |
ISBN: |
1098-2361 |
Abstract:
Abstract 10.1002/zoo.20269.abs Capybaras (Hydrochoerus hydrochaeris) are the world’s largest rodent. Owing to its uniqueness, 50 AZA institutions in North America display this species. As shown by a survey, no standard anesthetic protocol has been developed for this species. As a part of an ongoing behavioral study in Venezuela, capybaras were surgically implanted with radio transmitters. Animals were randomly assigned to one of the three immobilization protocols: (1) Tiletamine HCl/Zolazepam HCl, (2) Tiletamine HCl/Zolazepam HCl/Medetomidine HCl, and (3) Tiletamine HCl/Zolazepam HCl/Medetomidine HCl/Butorphanol tartrate. The protocol recommended for minimally invasive procedures when inhalant anesthetics are unavailable is a combination of Tiletamine HCl/Zolazepam HCl/Medetomidine HCl/Butorphanol tartrate. This is based on ease of administration, volume, onset of action, depth of anesthetic achieved, reversibility, safety, and costs. Zoo Biol 29:59–67, 2010. © 2009 Wiley-Liss, Inc.